Evaluation of epidermal growth factor receptor tyrosine kinase inhibitors combined with chemotherapy: Is there a need for a more rational design?

Xu Jian-Ming, Paradiso Angelo, McLeod Howard L

Eur J Cancer. 2004 Aug;40(12):1807-9. doi: 10.1016/j.ejca.2004.04.028.

Abstract

摘要

相似文献

Eur J Cancer. 2004 Aug;40(12):1807-9. doi: 10.1016/j.ejca.2004.04.028.

Curr Opin Oncol. 2007 Mar;19(2):98-102. doi: 10.1097/CCO.0b013e328011beec.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 2):1061s-1068s. doi: 10.1158/1078-0432.CCR-05-2125.

Clin Cancer Res. 2006 Jul 15;12(14 Pt 2):4451s-4457s. doi: 10.1158/1078-0432.CCR-06-0095.

Oncol Rep. 2007 Feb;17(2):465-9.

Oncologist. 2006 Jun;11(6):602-11. doi: 10.1634/theoncologist.11-6-602.

Chem Biol Drug Des. 2009 Apr;73(4):380-7. doi: 10.1111/j.1747-0285.2009.00786.x.

Clin Cancer Res. 2005 Jul 1;11(13):4923-33. doi: 10.1158/1078-0432.CCR-04-2060.

Semin Oncol. 2006 Feb;33(1 Suppl 1):S25-31. doi: 10.1053/j.seminoncol.2005.12.005.

Int J Oncol. 2008 Nov;33(5):1107-13.

Sci Rep. 2018 Nov 8;8(1):16579. doi: 10.1038/s41598-018-34938-y.

BMC Cancer. 2006 Dec 16;6:288. doi: 10.1186/1471-2407-6-288.

World J Gastroenterol. 2006 Aug 28;12(32):5140-7. doi: 10.3748/wjg.v12.i32.5140.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。